Chronic hepatitis C in HIV-coinfected patients: feasibility and efficacy of interferon-alpha2b and ribavirin combination therapy

J Acquir Immune Defic Syndr. 2001 Mar 1;26(3):299-300. doi: 10.1097/00042560-200103010-00016.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Hepacivirus / isolation & purification
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • RNA, Viral / blood
  • Recombinant Proteins
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ribavirin / therapeutic use*

Substances

  • Anti-HIV Agents
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Reverse Transcriptase Inhibitors
  • Ribavirin